Preterm Infant Intestinal Microbiota Development and Maternal Fecal Transplant - Trial NCT06227845
Access comprehensive clinical trial information for NCT06227845 through Pure Global AI's free database. This phase not specified trial is sponsored by Otto Helve and is currently Not yet recruiting. The study focuses on Microbial Colonization. Target enrollment is 36 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Otto Helve
Helsinki University Central Hospital
Timeline & Enrollment
N/A
Feb 01, 2024
Dec 01, 2026
Primary Outcome
Safety; Incidence of Treatment- Adverse Events eg. infections and increased need for respiratory support
Summary
The goal of this clinical trial is to study if a oral maternal fecal transplant given to a
 premature infant born by cesarean section (CS) is safe. The investigators will also compare
 the gut microbiome of the infants to those born by CS and not received the transplant and to
 premature infants born vaginally.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06227845
Non-Device Trial